NuPulseCV, Inc. is a Raleigh, NC based company working to transform the way advanced heart failure patients are treated.
NuPulseCV’s iVAS medical device (ambulatory counterpulsation) is being evaluated through a clinical trial as an option for patients who have advanced heart failure and who are no longer benefiting from guideline directed medical therapies. The iVAS is a less invasive option that may help address heart failure symptoms (NYHA III and IV), which may allow a heart failure patient to return to daily activities.
